199 related articles for article (PubMed ID: 36757032)
1. The ABCB1 C3435T Polymorphism is Associated with Triglyceride Reduction in Atorvastatin-treated Uygur Patients with Coronary Heart Disease and Dyslipidemia: An Observational Study.
Wang T; Wu J; Liu T; Xu L; Feng J; Zhang H; Shen H; Sun L; Li H; Yu L
Endocr Metab Immune Disord Drug Targets; 2023; 23(9):1215-1228. PubMed ID: 36757032
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China.
Wang T; Sun L; Xu L; Zhao T; Feng J; Yu L; Wu J; Li H
Lipids Health Dis; 2021 Sep; 20(1):116. PubMed ID: 34563206
[TBL] [Abstract][Full Text] [Related]
3. Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia.
Shabana MF; Mishriki AA; Issac MS; Bakhoum SW
Mol Diagn Ther; 2013 Oct; 17(5):299-309. PubMed ID: 23677857
[TBL] [Abstract][Full Text] [Related]
4. Impact of ABCB1 Polymorphism on Levetiracetam Serum Concentrations in Epileptic Uygur Children in China.
Zhao T; Yu J; Wang TT; Feng J; Zhao WB; Sun L; Yu LH; Li HJ; Sun Y
Ther Drug Monit; 2020 Dec; 42(6):886-892. PubMed ID: 32890316
[TBL] [Abstract][Full Text] [Related]
5. Association of ABCB1 polymorphisms with lipid homeostasis and liver injury response to atorvastatin in the Chinese population.
Qu KK; Zhang CN; Dong LX; Wang SS; Zhang ZD; Zhang L
Can J Physiol Pharmacol; 2020 Jan; 98(1):15-22. PubMed ID: 31574240
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia.
Zhang L; He S; Li Z; Gan X; Li S; Cheng X; Yang N; Zheng F
Lipids Health Dis; 2019 Jun; 18(1):129. PubMed ID: 31153375
[TBL] [Abstract][Full Text] [Related]
7. Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients.
Sam WJ; Chamberlain CE; Lee SJ; Goldstein JA; Hale DA; Mannon RB; Kirk AD; Hon YY
Transplantation; 2012 Nov; 94(9):971-7. PubMed ID: 23073467
[TBL] [Abstract][Full Text] [Related]
8. CYP2C19, PON1, and ABCB1 gene polymorphisms in Han and Uygur populations with coronary artery disease in Northwestern Xinjiang, China, From 2014 Through 2019.
Wang T; Zhao T; Bao S; Jia L; Feng J; Yu A; Sun L; Guo X; Li H; Yu L
Medicine (Baltimore); 2020 Jul; 99(29):e20582. PubMed ID: 32702814
[TBL] [Abstract][Full Text] [Related]
9. Effect of ABCB1 genotype on pre- and post-cardiac transplantation plasma lipid concentrations.
Taegtmeyer AB; Breen JB; Smith J; Rogers P; Kullak-Ublick GA; Yacoub MH; Banner NR; Barton PJ
J Cardiovasc Transl Res; 2011 Jun; 4(3):304-12. PubMed ID: 21445698
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiological survey on lipid levels in adults with Han, Uygur and Kazakh ethnicities from Xinjiang, China].
Li Y; Ma YT; Yu ZX; Yang YN; Li XM; Xie X; Liu F; Chen Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jun; 33(6):567-71. PubMed ID: 22883261
[TBL] [Abstract][Full Text] [Related]
11. ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment.
Rebecchi IM; Rodrigues AC; Arazi SS; Genvigir FD; Willrich MA; Hirata MH; Soares SA; Bertolami MC; Faludi AA; Bernik MM; Dorea EL; Dagli ML; Avanzo JL; Hirata RD
Biochem Pharmacol; 2009 Jan; 77(1):66-75. PubMed ID: 18851956
[TBL] [Abstract][Full Text] [Related]
12. Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
Poduri A; Khullar M; Bahl A; Sehrawat BS; Sharma Y; Talwar KK
DNA Cell Biol; 2010 Oct; 29(10):629-37. PubMed ID: 20578904
[TBL] [Abstract][Full Text] [Related]
13. Impact of ABCB1 Polymorphisms on Lacosamide Serum Concentrations in Uygur Pediatric Patients With Epilepsy in China.
Zhao T; Li HJ; Feng J; Zhang HL; Ting-Ting W; Ma L; Yu J; Zhao WB; Sun L; Yu LH; Sun Y
Ther Drug Monit; 2022 Jun; 44(3):455-464. PubMed ID: 34610620
[TBL] [Abstract][Full Text] [Related]
14. Increased risk for congenital heart defects in children carrying the ABCB1 Gene C3435T polymorphism and maternal periconceptional toxicants exposure.
Wang C; Xie L; Zhou K; Zhan Y; Li Y; Li H; Qiao L; Wang F; Hua Y
PLoS One; 2013; 8(7):e68807. PubMed ID: 23874772
[TBL] [Abstract][Full Text] [Related]
15. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment.
Akiyama M; Mawatari T; Nakashima Y; Miyahara H; Yamada H; Okazaki K; Fukushi J; Kondo M; Kishimoto J; Hashimura C; Iwamoto Y
Clin Rheumatol; 2015 Nov; 34(11):1867-75. PubMed ID: 26292631
[TBL] [Abstract][Full Text] [Related]
17.
Chouchi M; Klaa H; Ben-Youssef Turki I; Hila L
Dis Markers; 2019; 2019():1343650. PubMed ID: 31871496
[TBL] [Abstract][Full Text] [Related]
18. Transporter genes ABCG2 rs2231142 and ABCB1 rs1128503 polymorphisms and atorvastatin response in Chilean subjects.
Prado Y; Zambrano T; Salazar LA
J Clin Pharm Ther; 2018 Feb; 43(1):87-91. PubMed ID: 28833323
[TBL] [Abstract][Full Text] [Related]
19.
Bharath G; Vishnuprabu DP; Preethi L; Nagappan AS; Dhianeshwaran Isravanya RT; Bhaskar LV; Swaminathan N; Munirajan AK
Pharmacogenomics; 2022 Aug; 23(12):683-694. PubMed ID: 35968761
[No Abstract] [Full Text] [Related]
20. The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention.
Wang T; Li H; Wang F; Sun L; Yu L
Eur J Clin Pharmacol; 2021 Nov; 77(11):1679-1686. PubMed ID: 34164723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
